Prognostic impacts of hypoxic markers in soft tissue sarcoma

Area of Science:

• Oncology
• Pathology
• Molecular Biology

Background:

• Soft tissue sarcomas (STS) are a heterogeneous group of cancers.
• Hypoxia, a low-oxygen environment, plays a role in tumor progression.
• Hypoxia-induced factors (HIFs) and their downstream targets are implicated in cancer survival.

Purpose of the Study:

• To investigate the prognostic value of hypoxia-related markers in non-gastrointestinal stromal tumor soft tissue sarcomas (non-GIST STS).
• Specifically, to assess the impact of hypoxia-induced factors (HIFαs) 1 and 2, glucose transporter 1 (GLUT-1), and carbonic anhydrase IX (CAIX).

Main Methods:

• Tissue microarrays were constructed from 206 non-GIST STS patient samples.
• Immunohistochemistry (IHC) was employed to evaluate the expression levels of hypoxic markers.
• Univariate and multivariate survival analyses were performed.

Main Results:

• Univariate analysis showed significant correlations between GLUT-1 and HIF-2α expression and poor disease-specific survival (DSS).
• Multivariate analysis identified high GLUT-1 expression as an independent negative prognostic indicator for DSS (HR 1.7, P = 0.021).
• HIF-2α did not remain a significant independent prognostic factor in the multivariate model.

Conclusions:

• Glucose transporter 1 (GLUT-1) is a significant independent negative prognostic factor in non-GIST STS.
• High GLUT-1 expression is associated with reduced disease-specific survival.
• These findings highlight GLUT-1 as a potential therapeutic target in non-GIST STS.